Alzheimer's Therapeutics Targeting Amyloid Beta 1–42 Oligomers II: Sigma-2/PGRMC1 Receptors Mediate Abeta 42 Oligomer Binding and Synaptotoxicity
暂无分享，去创建一个
R. Mach | A. Goate | C. Cruchaga | G. Rishton | O. Arancio | T. Spires-Jones | H. Levine | M. Cahill | E. Head | G. Look | C. Zeng | Jinbin Xu | R. Craven | N. Izzo | Raymond Yurko | Molly J. Kirk | Susan M. Catalano | Kelsie Mozzoni | Colleen Silky | Courtney Rehak | Hank Safferstein